Methylthioninium API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Methylthioninium is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Methylthioninium or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Methylthioninium API 7060-82-4?

Description:
Here you will find a list of producers, manufacturers and distributors of Methylthioninium. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Methylthioninium 
Synonyms:
Methylene blue cation  
Cas Number:
7060-82-4 
DrugBank number:
DB08167 
Unique Ingredient Identifier:
ZMZ79891ZH

General Description:

Methylthioninium is a chemical compound identified by the CAS number 7060-82-4. It is known for its distinct pharmacological properties and applications.

Classification:

Methylthioninium belongs to the class of organic compounds known as benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom), classified under the direct parent group Benzothiazines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Benzothiazines class, specifically within the None subclass.

Categories:

Methylthioninium is categorized under the following therapeutic classes: Oxidation-Reduction Activity, Oxidation-Reduction Agent, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.